0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Diseases & disorders > Infectious & contagious diseases

Not currently available

Global Crisis of Drug-Resistant Tuberculosis and Leadership of China and the BRICS - Challenges and Opportunities: Summary of a Joint Workshop by the Institute of Medicine and the Institute of Microbiology, Chinese Academy of Sciences (Paperback) Loot Price: R1,057
Discovery Miles 10 570
Global Crisis of Drug-Resistant Tuberculosis and Leadership of China and the BRICS - Challenges and Opportunities: Summary of a...

Global Crisis of Drug-Resistant Tuberculosis and Leadership of China and the BRICS - Challenges and Opportunities: Summary of a Joint Workshop by the Institute of Medicine and the Institute of Microbiology, Chinese Academy of Sciences (Paperback)

Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine; Edited by Steve Olson, Rebecca A. English, Anne B. Claiborne

 (sign in to rate)
Loot Price R1,057 Discovery Miles 10 570 | Repayment Terms: R99 pm x 12*

Bookmark and Share

Supplier out of stock. If you add this item to your wish list we will let you know when it becomes available.

Multidrug-resistant tuberculosis (TB) is caused by bacteria resistant to isoniazid and rifampicin, the two most effective first-line anti-TB drugs, originally developed and introduced in the 1950 and 1960s. Since 2008, the Forum on Drug Discovery, Development, and Translation of the Institute of Medicine has hosted or co-hosted six domestic and international workshops addressing the global crisis of drug-resistant TB, with special attention to the BRICS countries - Brazil, Russia, India, China, and South Africa. The Global Crisis of Drug-Resistant Tuberculosis and Leadership of China and the BRICS is the summary of a workshop convened to address the current status of drug-resistant TB globally and in China. This report considers lessons learned from high burden countries; highlights global challenges to controlling the spread of drug-resistant strains; and discusses innovative strategies to advance and harmonize local and international efforts to prevent and treat drug-resistant TB. Additionally, the report examines the problem of MDR TB and emergent TB strains that are potentially untreatable with drugs available and considers the critical leadership role of the BRICS countries in addressing the threats and opportunities in drug-resistant TB.

General

Imprint: National Academies Press
Country of origin: United States
Release date: March 2014
Authors: Forum on Drug Discovery, Development, and Translation • Board on Health Sciences Policy • Institute of Medicine
Editors: Steve Olson • Rebecca A. English • Anne B. Claiborne
Dimensions: 229 x 152 x 0mm (L x W x T)
Format: Paperback
Pages: 218
ISBN-13: 978-0-309-28596-4
Categories: Books > Medicine > General issues > Public health & preventive medicine > General
Books > Medicine > Clinical & internal medicine > Diseases & disorders > Infectious & contagious diseases > General
LSN: 0-309-28596-8
Barcode: 9780309285964

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners